Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Down 81.3% in October

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the recipient of a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 300 shares, a drop of 81.3% from the October 15th total of 1,600 shares. Based on an average trading volume of 3,200 shares, the days-to-cover ratio is presently 0.1 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Performance

Shares of HROWM traded up $0.16 on Tuesday, reaching $26.50. The company’s stock had a trading volume of 2,120 shares, compared to its average volume of 4,066. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 12-month low of $22.71 and a 12-month high of $27.72. The stock’s 50 day simple moving average is $26.48 and its two-hundred day simple moving average is $26.39.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th were given a dividend of $0.7422 per share. This represents a $2.97 annualized dividend and a dividend yield of 11.20%. The ex-dividend date was Tuesday, October 15th.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.